Eltrombopag Olamine Tablet, Film Coated
Product Images NDC 60219-1415

This text provides information about a medication with the NDC 60219-1417-3, containing eltrombopag olamine in a film-coated tablet form. Each tablet contains 15.95mg of eltrombopag olamine, equivalent to 12.5 mg of eltrombopag free acid. The recommended dosage is not provided in the text, but it suggests referring to accompanying prescribing information. The storage instructions indicate to store the tablets at room temperature between 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F). The text also includes guidance on not splitting, chewing, or crushing the tablets, keeping them out of the reach of children, and dispensing in the original bottle. It further mentions relevant manufacturing and distribution details of the product.*

This is a description for a prescription medicine labeled as NDC 60219-1416-3. The film-coated tablet contains eftrombopag olamine which is equivalent to 25 mg of eltrombopag free acid. The recommended dosage information is included in the prescribing information. The tablets should be stored at room temperature and important instructions include swallowing them whole, using safety closures when dispensing, and not splitting, chewing, or crushing the tablets. A Medication Guide should be provided separately for each patient. The medicine is distributed by Amneal Pharmaceuticals LLC and the manufacturing details indicate it is produced by Amneal Pharmaceuticals Pt. Ltd. It also includes a GTIN code, serial number, expiration date, and lot number for tracking purposes.*

Each film-coated tablet contains eltrombopag olamine 63.80 mg, equivalent to 50 mg eltrombopag free acid. The recommended dosage of eltrombopag is to be determined by accompanying prescribing information. Store the tablets at room temperature between 20° to 25°C (68° to 77°F), with excursions allowed between 15° to 30°C (59° to 86°F). Ensure to dispense in the original bottle and use safety closures. These tablets are to be swallowed whole, unless otherwise directed by a physician or purchaser. Keep this product out of the reach of children and do not use if the printed safety seal is broken or missing. Manufactured by Amneal Pharmaceuticals and distributed by the same company.*

Each film-coated tablet of NDC 60219-1414-3 contains eltrombopag olamine 95.70 mg, equivalent to 75 mg of eltrombopag free acid. The recommended dosage is provided in the accompanying prescribing information. Store the tablets at room temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). Remember to dispense in the original bottle and use safety closures when dispensing the product, following physician directions. Keep out of reach of children and do not use if the safety seal is broken or missing. This product is manufactured by Amneal Pharmaceuticals Pvt. Ltd. in India and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. The package contains 30 tablets with unvarnished area for batch coding details to be printed online. The product has a GTIN of X00000000000KK and a SRNO of X000.*